PTJ
BNR

Paul Tudor Jones’s Burning Rock Biotech BNR Stock Holding History

Paul Tudor Jones’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,585
Closed -$597K – 1564
2020
Q4 		$597K Buy
+2,585
New +$694K 0.02% 885

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Paul Tudor Jones's BNR Position: Q1 2021 in Review

Paul Tudor Jones sold out of Burning Rock Biotech (BNR) in Q1 2021, closing a stake of 2,585 shares — an estimated $597K sold.

Paul Tudor Jones first reported a position in BNR in Q4 2020 and held it in 1 quarter. The position peaked at $597K in Q4 2020. 54 funds tracked by Wall St. Rank hold BNR as of Q1 2021.

  • Paul Tudor Jones reported no remaining Burning Rock Biotech position as of Q1 2021 after selling out during the quarter.
  • Paul Tudor Jones sold 2,585 Burning Rock Biotech shares in Q1 2021, an estimated $597K.
  • Paul Tudor Jones first reported a position in Burning Rock Biotech in Q4 2020 and held it in 1 quarter.
  • Paul Tudor Jones's Burning Rock Biotech position peaked at $597K in Q4 2020.
  • 54 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2021.

Based on Tudor Investment Corp's 13F filing for Q1 2021, filed 17 May 2021.